With the parent acetylene and [RuCp(IPr)(CH 3 CN) 2 ]PF 6 (IPr = 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene) an unusual C−C coupling process takes place involving three acetylene molecules and migration of the NHC ligand to give the formal [2 + 2 + 1] cycloaddition product [RuCp(η 4 -C 5 H 5 -η 1 -CH-IPr)]PF 6 . This complex undergoes a facile 1,2-H shift to afford the (ruthenocenylmethyl)imidazolium salt [RuCp(η 5 -C 5 H 4 -CH 2 -IPr)]PF 6 . The same reaction takes place with [RuCp(SIPr)(CH 3 CN) 2 ]PF 6 (SIPr = 1,3-bis(2,6-diisopropylphenyl)-4,5-dihydroimidazol-2-ylidene), giving [RuCp(η 5 -C 5 H 4 -CH 2 -SIPr)]PF 6 . A conceivable mechanism for this reaction sequence is established by means of DFT/B3LYP calculations. The key step is the facile insertion of acetylene into the Ru−C bond of the NHC ligand, requiring merely 4.1 kcal/mol with 1,3-dimethylimidazol-2-ylidene but 17.2 kcal/mol with 1,3-diphenylimidazol-2-ylidene as model NHC ligands.
No takes yet. Share an insight, caveat, or question.
Becker et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: